ZA200702938B - Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositions - Google Patents
Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositionsInfo
- Publication number
- ZA200702938B ZA200702938B ZA200702938A ZA200702938A ZA200702938B ZA 200702938 B ZA200702938 B ZA 200702938B ZA 200702938 A ZA200702938 A ZA 200702938A ZA 200702938 A ZA200702938 A ZA 200702938A ZA 200702938 B ZA200702938 B ZA 200702938B
- Authority
- ZA
- South Africa
- Prior art keywords
- hsp60
- apl
- peptides
- pharmaceutical compositions
- type derivatives
- Prior art date
Links
- 102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 title 1
- 101710154868 60 kDa heat shock protein, mitochondrial Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20040207A CU23504A1 (es) | 2004-09-24 | 2004-09-24 | Péptidos y derivados tipo apl de la hsp60 y composiciones farmacéuticas |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200702938B true ZA200702938B (en) | 2008-08-27 |
Family
ID=40273413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200702938A ZA200702938B (en) | 2004-09-24 | 2007-04-10 | Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositions |
Country Status (17)
Country | Link |
---|---|
US (2) | US8383771B2 (de) |
EP (2) | EP2371847B1 (de) |
JP (1) | JP4755649B2 (de) |
KR (2) | KR101035283B1 (de) |
CN (2) | CN101935345B (de) |
AR (2) | AR051928A1 (de) |
AT (1) | ATE546462T1 (de) |
AU (2) | AU2005287757B2 (de) |
BR (2) | BRPI0515893B8 (de) |
CA (2) | CA2581110C (de) |
CU (1) | CU23504A1 (de) |
DK (2) | DK2371847T3 (de) |
ES (2) | ES2386498T3 (de) |
MX (1) | MX2007003624A (de) |
RU (1) | RU2361877C2 (de) |
WO (1) | WO2006032216A2 (de) |
ZA (1) | ZA200702938B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2915168C (en) * | 2007-01-30 | 2017-05-23 | Epivax, Inc. | Regulatory t cell epitopes, compositions and uses thereof |
CU23701A1 (es) * | 2008-12-29 | 2011-09-21 | Ct Ingenieria Genetica Biotech | Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i |
RU2596925C2 (ru) * | 2009-09-06 | 2016-09-10 | Протаб Лтд. | Гуманизированные антитела, специфические для пептида-6, полученного из hsp65, способы их использования |
US20110195905A1 (en) * | 2009-10-28 | 2011-08-11 | Argentis Pharmaceuticals, Llc | Apls for treating arthritis |
CU24508B1 (es) * | 2017-12-29 | 2021-04-07 | Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma | Composición farmacéutica que comprende péptido tipo apl |
CU20200026A7 (es) * | 2020-04-13 | 2021-11-04 | Ct Ingenieria Genetica Biotecnologia | Péptido para el tratamiento del síndrome de la tormenta de citocinas |
CN111870697B (zh) * | 2020-09-18 | 2022-09-09 | 山东鲁抗医药股份有限公司 | 糖类物质在提高apl型衍生肽稳定性中的应用和冻干组合物 |
KR102333645B1 (ko) | 2021-07-27 | 2021-12-02 | (주)문화전기 | 각도조절이 용이한 엘이디조명시스템 |
CN117883547A (zh) * | 2021-07-30 | 2024-04-16 | 河北菲尼斯生物技术有限公司 | Se-dr亲和肽在制备治疗风湿疾病的药物中的用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8701163A (nl) | 1986-09-09 | 1988-04-05 | Nederlanden Staat | Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits. |
NL8703107A (nl) | 1987-12-22 | 1989-07-17 | Nederlanden Staat | Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten. |
US5773570A (en) | 1994-05-20 | 1998-06-30 | The Regents Of The University Of California | Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
GB9419553D0 (en) | 1994-09-27 | 1994-11-16 | Univ Bristol | Polypeptides and their use in the treatment of auto-immune disease |
US6180103B1 (en) | 1994-12-21 | 2001-01-30 | Yeda Research And Development Co., Ltd. | Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
GB9519737D0 (en) * | 1995-09-27 | 1995-11-29 | Peptide Therapeutics Ltd | Polypeptides and their use in treatment and prophylaxis of auto-immune |
US5993803A (en) | 1996-08-30 | 1999-11-30 | Yeda Research And Development Co., Ltd. | Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity |
GB9911772D0 (en) | 1999-05-21 | 1999-07-21 | Semmelweis University Of Medic | Diagnosis and treatment of atherosclerosis |
US20020169302A1 (en) * | 1999-08-23 | 2002-11-14 | Genesis Research And Development Corp. Ltd. | Compositions isolated from bovine mammary gland and methods for their use |
WO2001043691A2 (en) | 1999-12-15 | 2001-06-21 | Peptor Ltd. | Fragments and antagonists of heat shock protein 60 |
WO2002057795A2 (en) | 2001-01-19 | 2002-07-25 | Cambridge Scientific, Inc. | Methods of diagnosis and treatment of osteoporosis |
-
2004
- 2004-09-24 CU CU20040207A patent/CU23504A1/es active IP Right Grant
-
2005
- 2005-09-21 AR ARP050103950A patent/AR051928A1/es active IP Right Grant
- 2005-09-22 DK DK10189769.2T patent/DK2371847T3/da active
- 2005-09-22 RU RU2007115411/04A patent/RU2361877C2/ru active
- 2005-09-22 US US11/663,603 patent/US8383771B2/en active Active
- 2005-09-22 BR BRPI0515893A patent/BRPI0515893B8/pt active IP Right Grant
- 2005-09-22 ES ES05794474T patent/ES2386498T3/es active Active
- 2005-09-22 CN CN2010100038161A patent/CN101935345B/zh active Active
- 2005-09-22 ES ES10189769.2T patent/ES2445707T3/es active Active
- 2005-09-22 EP EP10189769.2A patent/EP2371847B1/de active Active
- 2005-09-22 KR KR1020107001135A patent/KR101035283B1/ko active IP Right Grant
- 2005-09-22 KR KR1020077008682A patent/KR101054332B1/ko active IP Right Grant
- 2005-09-22 WO PCT/CU2005/000008 patent/WO2006032216A2/es active Application Filing
- 2005-09-22 CA CA2581110A patent/CA2581110C/en active Active
- 2005-09-22 DK DK05794474.6T patent/DK1803732T3/da active
- 2005-09-22 JP JP2007532752A patent/JP4755649B2/ja active Active
- 2005-09-22 AT AT05794474T patent/ATE546462T1/de active
- 2005-09-22 EP EP05794474A patent/EP1803732B1/de active Active
- 2005-09-22 CN CN2005800403891A patent/CN101065398B/zh active Active
- 2005-09-22 AU AU2005287757A patent/AU2005287757B2/en not_active Ceased
- 2005-09-22 MX MX2007003624A patent/MX2007003624A/es active IP Right Grant
- 2005-09-22 CA CA2797769A patent/CA2797769C/en active Active
- 2005-09-22 BR BR122018077204A patent/BR122018077204B8/pt active IP Right Grant
-
2007
- 2007-04-10 ZA ZA200702938A patent/ZA200702938B/xx unknown
-
2009
- 2009-12-28 AR ARP090105137A patent/AR074924A2/es active IP Right Grant
- 2009-12-30 US US12/649,687 patent/US8324164B2/en active Active
-
2010
- 2010-09-06 AU AU2010219312A patent/AU2010219312B2/en not_active Ceased
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1221252A1 (zh) | 限制的 肽及含有其的藥物組合物 | |
EP1933862A4 (de) | Verfahren und zusammensetzungen zur oralen verabreichung von proteinen | |
IL178070A (en) | Antibiotic p-selectin antibodies and pharmaceuticals that include them | |
IL190292A (en) | History of pyridopyrimidinone and their pharmaceutical preparations | |
EP1773369A4 (de) | Pharmazeutische zusammensetzungen und verfahren für die peptidbehandlung | |
ZA200702938B (en) | Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositions | |
EP1765379A4 (de) | Pharmazeutische ko-kristallzusammensetzungen und relevante anwendungsverfahren | |
IL186959A0 (en) | Peptides and pharmaceutical compositions containing the same | |
IL194429A0 (en) | Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same | |
IL177168A0 (en) | N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same | |
IL184735A0 (en) | Pharmaceutical formulations and methods of use | |
EP1890677A4 (de) | Pharmazeutische zusammensetzungen und ihre verwendung | |
IL221323A0 (en) | 1-methyl-1h- pyridin-2-one- phenanthridine derivatives and pharmaceutical compositions containing the same | |
EP1890720A4 (de) | Pharmazeutische zusammensetzungen mit von casein stammenden peptiden und anwendungsverfahren dafür | |
IL170313A (en) | Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them | |
IL178067A0 (en) | Pharmaceutical dosage forms and compositions | |
IL183986A0 (en) | Pharmaceutical compounds and compositions | |
IL221395A0 (en) | Pharmaceutical compositions comprising alpha ketoamide derivatives and uses thereof | |
ZA200702038B (en) | Pharmaceutical composition drospirenone and ethynyle-stradiol | |
IL181730A0 (en) | Benzodiazinone derivatives and pharmaceutical compositions containing the same | |
IL177498A0 (en) | Difluoroethoxy -substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same | |
EP1884510A4 (de) | N-substituiertes phenylacetamidderivat und pharmazeutische zusammensetzung, die dieses enthält | |
GB0404327D0 (en) | Pharmaceutical composition and method of using same | |
IL177497A0 (en) | Isoamido-substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same | |
ZA200700178B (en) | Pharmaceutical composition containing polypeptide fragments of serralysins |